-
1
-
-
33744913863
-
Esophageal cancer: International guidelines in interdisciplinary diagnosis and treatment
-
Zacherl J, Neumayer C, Langer F. Esophageal cancer: International guidelines in interdisciplinary diagnosis and treatment. Eur Surg 2006;38:79-88
-
(2006)
Eur Surg
, vol.38
, pp. 79-88
-
-
Zacherl, J.1
Neumayer, C.2
Langer, F.3
-
2
-
-
0032585510
-
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
-
Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-84
-
(1998)
N Engl J Med
, vol.339
, pp. 1979-1984
-
-
Kelsen, D.P.1
Ginsberg, R.2
Pajak, T.F.3
-
3
-
-
0037129734
-
Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial
-
MRC
-
MRC. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 2002;359:1727-33
-
(2002)
Lancet
, vol.359
, pp. 1727-1733
-
-
-
4
-
-
0035863382
-
Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma
-
Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-13
-
(2001)
J Clin Oncol
, vol.19
, pp. 305-313
-
-
Urba, S.G.1
Orringer, M.B.2
Turrisi, A.3
-
5
-
-
43049093034
-
Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer
-
Kandioler D, Stamatis G, Eberhardt W, et al. Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer. J Thorac Cardiovasc Surg 2008;135:1036-41
-
(2008)
J Thorac Cardiovasc Surg
, vol.135
, pp. 1036-1041
-
-
Kandioler, D.1
Stamatis, G.2
Eberhardt, W.3
-
6
-
-
0036208768
-
TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer
-
Kandioler D, Zwrtek R, Ludwig C, et al. TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer. Ann Surg 2002;235:493-8
-
(2002)
Ann Surg
, vol.235
, pp. 493-498
-
-
Kandioler, D.1
Zwrtek, R.2
Ludwig, C.3
-
7
-
-
0033971806
-
TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients
-
Kandioler-Eckersberger D, Ludwig C, Rudas M, et al. TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients. Clin Cancer Res 2000;6:50-6
-
(2000)
Clin Cancer Res
, vol.6
, pp. 50-56
-
-
Kandioler-Eckersberger, D.1
Ludwig, C.2
Rudas, M.3
-
8
-
-
0018387446
-
Promotion of microtubule assembly in vitro by taxol
-
Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979;277:665-7
-
(1979)
Nature
, vol.277
, pp. 665-667
-
-
Schiff, P.B.1
Fant, J.2
Horwitz, S.B.3
-
9
-
-
33644749184
-
Basic principles in the planning of clinical trials in surgical oncology
-
Draxler W, Mittlböck M. Basic principles in the planning of clinical trials in surgical oncology. Eur Surg 2006;38:27-32
-
(2006)
Eur Surg
, vol.38
, pp. 27-32
-
-
Draxler, W.1
Mittlböck, M.2
-
10
-
-
63349110017
-
p53 adapted neoadjuvant therapy for esophageal cancer: Pilot study
-
(abstract 4535)
-
Kandioler D, Hejna M, Zwrtek R, et al. p53 adapted neoadjuvant therapy for esophageal cancer: Pilot study. J Clin Oncol 2007;25:201s (abstract 4535)
-
(2007)
J Clin Oncol
, vol.25
-
-
Kandioler, D.1
Hejna, M.2
Zwrtek, R.3
-
11
-
-
15744374441
-
Clinical trial designs for predictive marker validation in cancer treatment trials
-
Sargent DJ, Conley BA, Allegra C, et al. Clinical trial designs for predictive marker validation in cancer treatment trials. J Clin Oncol 2005;23:2020-7
-
(2005)
J Clin Oncol
, vol.23
, pp. 2020-2027
-
-
Sargent, D.J.1
Conley, B.A.2
Allegra, C.3
-
12
-
-
63349105181
-
Personalized medicine - p53 gene analysis for prediction of response to neoadjuvant therapy in esophageal cancer
-
Kandioler D. Personalized medicine - p53 gene analysis for prediction of response to neoadjuvant therapy in esophageal cancer. Memo 2008;1:137-42
-
(2008)
Memo
, vol.1
, pp. 137-142
-
-
Kandioler, D.1
-
13
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
-
14
-
-
33644771106
-
Oncological surgery and standards in surgical pathology
-
Wrba F. Oncological surgery and standards in surgical pathology. Eur Surg 2006;38:38-40
-
(2006)
Eur Surg
, vol.38
, pp. 38-40
-
-
Wrba, F.1
-
15
-
-
34547113305
-
Editorial: Treatment of esophageal cancer - Part I
-
Zacherl J. Editorial: Treatment of esophageal cancer - Part I. Eur Surg 2007;39:135-5
-
(2007)
Eur Surg
, vol.39
, pp. 135-135
-
-
Zacherl, J.1
|